| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $696.6M | — | +38.8% |
| R&D Expense | $210.7M | — | +63.2% |
| SG&A Expense | $327.9M | — | +22.9% |
| Operating Income | -$93.5M | — | -18.1% |
| Pre-tax Income | -$84.8M | — | -27.0% |
| Income Tax | $283K | — | +63.6% |
| Net Income | -$85.1M | — | -27.1% |
| EPS (Basic) | -$0.60 | — | -20.0% |
| EPS (Diluted) | -$0.60 | — | -20.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $417.6M | +40.8% | +31.2% |
| Inventory | $70.7M | +3.3% | +40.4% |
| Current Assets | $1.65B | +10.3% | +16.6% |
| Total Assets | $2.61B | +9.0% | +50.9% |
| Current Liabilities | $558.3M | +26.5% | +52.7% |
| Total Liabilities | $840.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $40.2M | — | -9.6% |
| Capital Expenditures | $22.1M | — | +1.5% |
| Investing Cash Flow | -$32.1M | — | -91.1% |
| Financing Cash Flow | $3.8M | — | +590.8% |
| Free Cash Flow | $18.0M | — | -20.3% |
| +70.6% |
| Stockholders' Equity | $1.77B | +3.6% | +43.1% |